GeneDx (WGS) Short Interest Ratio & Short Volume

$11.08
-0.09 (-0.81%)
(As of 04/26/2024 ET)

GeneDx Short Interest Data

Current Short Volume
1,070,000 shares
Previous Short Volume
1,100,000 shares
Change Vs. Previous Month
-2.73%
Dollar Volume Sold Short
$10.57 million
Short Interest Ratio / Days to Cover
5.0
Last Record Date
April 15, 2024
Outstanding Shares
26,054,000 shares
Float Size
16,220,000 shares
Short Percent of Float
6.60%
Today's Trading Volume
148,889 shares
Average Trading Volume
140,830 shares
Today's Volume Vs. Average
106%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling GeneDx ?

Sign up to receive the latest short interest report for GeneDx and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

WGS Short Interest Over Time

WGS Days to Cover Over Time

WGS Percentage of Float Shorted Over Time

GeneDx Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/20241,070,000 shares $10.57 million -2.7%6.6%5 $9.88
3/31/20241,100,000 shares $10.04 million +4.8%6.8%4.2 $9.13
3/15/20241,050,000 shares $12.61 million -4.6%6.5%3.8 $12.01
2/29/20241,100,000 shares $8.97 million -9.1%6.8%3.7 $8.15
2/15/20241,210,000 shares $5.38 million +14.2%7.5%3.1 $4.45
1/31/20241,060,000 shares $4.08 million +6.9%6.9%2.7 $3.85
1/15/2024991,900 shares $3.63 million +44.7%6.4%2.5 $3.66
12/31/2023685,700 shares $1.89 million +9.4%4.4%2 $2.75
12/15/2023626,600 shares $1.52 million -16.5%4.0%2 $2.43
11/30/2023750,100 shares $1.31 million +15.2%4.8%2.8 $1.75
11/15/2023651,400 shares $840,306.00 -16.4%4.2%2.9 $1.29
10/31/2023779,100 shares $1.45 million +1.7%5.0%8.5 $1.86
10/15/2023765,900 shares $2.47 million +8.7%4.9%10.2 $3.23
9/30/2023704,500 shares $2.56 million -2.7%4.5%9.6 $3.64
9/15/2023724,300 shares $3.17 million +2.6%4.7%7.8 $4.38
8/31/2023705,700 shares $3.14 million +1.4%4.2%5.4 $4.45
8/15/2023696,200 shares $3.57 million -2.3%4.2%4.3 $5.13
7/31/2023712,600 shares $5.28 million -0.8%4.3%4.1 $7.41
7/15/2023718,200 shares $4.83 million -6.9%4.3%3.9 $6.72
6/30/2023771,500 shares $4.60 million -18.7%4.6%4.4 $5.96
6/15/2023949,200 shares $6.95 million +18.8%5.7%5.8 $7.32
5/31/2023798,700 shares $6.01 million +7.8%4.9%5.1 $7.52
5/15/2023740,800 shares $5.32 million No Change4.6%5.6 $7.18
12/15/20224,770,000 shares $1.34 million -25.2%2.8%2.8 $0.28
11/30/20226,380,000 shares $2.64 million -35.9%3.9%4.5 $0.41
11/15/20229,950,000 shares $8.76 million -8.1%6.0%9.6 $0.88
10/31/202210,830,000 shares $11.15 million -1.5%6.7%8.8 $1.03
10/15/202210,990,000 shares $9.42 million -4.0%6.8%8.8 $0.86
9/30/202211,450,000 shares $10.05 million +1.2%7.0%8.7 $0.88
9/15/202211,320,000 shares $11.32 million -5.0%7.0%6.3 $1.00
8/31/202211,920,000 shares $12.16 million -1.2%7.4%5.6 $1.02
8/15/202212,060,000 shares $28.94 million -19.8%7.5%5.3 $2.40
7/31/202215,030,000 shares $24.35 million +10.3%9.4%6.9 $1.62
7/15/202213,630,000 shares $21.54 million +9.9%8.5%5.8 $1.58
6/30/202212,400,000 shares $15.62 million +18.3%7.7%5.3 $1.26
6/15/202210,480,000 shares $15.20 million +11.4%6.5%4.6 $1.45
5/31/20229,410,000 shares $19.20 million +22.7%5.9%5.3 $2.04
5/15/20227,670,000 shares $15.72 million +61.8%4.8%4.8 $2.05
4/30/20224,740,000 shares $10.19 million -1.9%4.0%3.3 $2.15
4/15/20224,830,000 shares $12.61 million -1.0%4.1%3.4 $2.61
Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (Ad)

If you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)

Watch my video for all of the details

WGS Short Interest - Frequently Asked Questions

What is GeneDx's current short interest?

Short interest is the volume of GeneDx shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 1,070,000 shares of WGS short. 6.60% of GeneDx's shares are currently sold short. Learn More on GeneDx's current short interest.

What is a good short interest ratio for GeneDx?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. WGS shares currently have a short interest ratio of 5.0. Learn More on GeneDx's short interest ratio.

Which institutional investors are shorting GeneDx?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of GeneDx: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for GeneDx?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.60% of GeneDx's floating shares are currently sold short.

Is GeneDx's short interest increasing or decreasing?

GeneDx saw a drop in short interest during the month of April. As of April 15th, there was short interest totaling 1,070,000 shares, a drop of 2.7% from the previous total of 1,100,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is GeneDx's float size?

GeneDx currently has issued a total of 26,050,000 shares. Some of GeneDx's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. GeneDx currently has a public float of 16,220,000 shares.

How does GeneDx's short interest compare to its competitors?

6.60% of GeneDx's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to GeneDx: Sharecare, Inc. (4.17%), DocGo Inc. (10.71%), P3 Health Partners Inc. (4.57%), Talkspace, Inc. (3.05%), InnovAge Holding Corp. (1.63%), The Pennant Group, Inc. (1.28%), Viemed Healthcare, Inc. (1.18%), Clover Health Investments, Corp. (9.72%), Nautilus Biotechnology, Inc. (1.95%), Aquestive Therapeutics, Inc. (5.47%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks.

What does it mean to sell short GeneDx stock?

Short selling WGS is an investing strategy that aims to generate trading profit from GeneDx as its price is falling. WGS shares are trading down $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against GeneDx?

A short squeeze for GeneDx occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of WGS, which in turn drives the price of the stock up even further.

How often is GeneDx's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including WGS, twice per month. The most recent reporting period available is April, 15 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:WGS) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners